Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Comparative Study of the Efficacy and Safety of Arsucam® Administered as a Single Daily Intake Versus Two Daily Intakes in the Treatment of Plasmodium Falciparum Malaria Attack

NCT00445796 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00445796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00445796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Comparative Study of the Efficacy and Safety of Arsucam® Administered as a Single Daily Intake Versus Two Daily Intakes in the Treatment of Plasmodium Falciparum Malaria Attack
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2005
Completion date
Not reported
Enrollment
300
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria